Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 27613370)

  • 1. Laser acupuncture attenuates oxaliplatin-induced peripheral neuropathy in patients with gastrointestinal cancer: a pilot prospective cohort study.
    Hsieh YL; Chou LW; Hong SF; Chang FC; Tseng SW; Huang CC; Yang CH; Yang CC; Chiu WF
    Acupunct Med; 2016 Oct; 34(5):398-405. PubMed ID: 27613370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound Acupuncture for Oxaliplatin-induced Peripheral Neuropathy in Patients With Colorectal Cancer: A Pilot Study.
    Chien A; Yang CC; Chang SC; Jan YM; Yang CH; Hsieh YL
    PM R; 2021 Jan; 13(1):55-65. PubMed ID: 32168417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of oxaliplatin-induced peripheral neuropathy by a polyamine-reduced diet-NEUROXAPOL: protocol of a prospective, randomised, controlled, single-blind and monocentric trial.
    Balayssac D; Ferrier J; Pereira B; Gillet B; Pétorin C; Vein J; Libert F; Eschalier A; Pezet D
    BMJ Open; 2015 Apr; 5(4):e007479. PubMed ID: 25833669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
    Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
    J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Sensory Testing at Baseline and During Cycle 1 Oxaliplatin Infusion Detects Subclinical Peripheral Neuropathy and Predicts Clinically Overt Chronic Neuropathy in Gastrointestinal Malignancies.
    Reddy SM; Vergo MT; Paice JA; Kwon N; Helenowski IB; Benson AB; Mulcahy MF; Nimeiri HS; Harden RN
    Clin Colorectal Cancer; 2016 Mar; 15(1):37-46. PubMed ID: 26337211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi.
    Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S
    Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is quantitative sensory testing helpful in the management of oxaliplatin neuropathy? a two-year clinical study.
    Delmotte JB; Beaussier H; Auzeil N; Massicot F; Laprévote O; Raymond E; Coudoré F
    Cancer Treat Res Commun; 2018; 17():31-36. PubMed ID: 30343217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study.
    Prinsloo S; Novy D; Driver L; Lyle R; Ramondetta L; Eng C; McQuade J; Lopez G; Cohen L
    Cancer; 2017 Jun; 123(11):1989-1997. PubMed ID: 28257146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malignancies receiving oxaliplatin-based chemotherapy: Study protocol for a randomized, controlled pilot and feasibility study.
    Cohen SA; Veleber S; Siman J; Guthrie KA; McMillen K; Heit M; Wadhera S; Daniels J; Hansen K; Jacoby M; Taromina K; Chin S; Romeo M; Langley BO; Coveler AL; Hannan LM; King G; Purcell T; Safyan RA; Shankaran V; Zhen DB; Chiorean EG; Greenlee H
    Contemp Clin Trials; 2023 Aug; 131():107273. PubMed ID: 37380021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-allodynic effect of Buja in a rat model of oxaliplatin-induced peripheral neuropathy via spinal astrocytes and pro-inflammatory cytokines suppression.
    Jung Y; Lee JH; Kim W; Yoon SH; Kim SK
    BMC Complement Altern Med; 2017 Jan; 17(1):48. PubMed ID: 28088201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness assessment of riluzole in the prevention of oxaliplatin-induced peripheral neuropathy: RILUZOX-01: protocol of a randomised, parallel, controlled, double-blind and multicentre study by the UNICANCER-AFSOS Supportive Care intergroup.
    Kerckhove N; Busserolles J; Stanbury T; Pereira B; Plence V; Bonnetain F; Krakowski I; Eschalier A; Pezet D; Balayssac D
    BMJ Open; 2019 Jun; 9(6):e027770. PubMed ID: 31182448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients.
    Hines RB; Schoborg C; Sumner T; Zhu X; Elgin EA; Zhang S
    Support Care Cancer; 2023 Jun; 31(7):386. PubMed ID: 37294347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in chemotherapy-induced peripheral neuropathy, disturbance in activities of daily living, and depression following chemotherapy in patients with colorectal cancer: A prospective study.
    Oh PJ; Lee JR; Kim SK; Kim JH
    Eur J Oncol Nurs; 2020 Feb; 44():101676. PubMed ID: 31751847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine improves oxaliplatin-induced neuropathy in patients with colorectal cancer: an open-label pilot study.
    Yang YH; Lin JK; Chen WS; Lin TC; Yang SH; Jiang JK; Chang SC; Lan YT; Lin CC; Yen CC; Tzeng CH; Wang WS; Chiang HL; Teng CJ; Teng HW
    Support Care Cancer; 2012 Jul; 20(7):1491-7. PubMed ID: 21814779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study.
    Kokotis P; Schmelz M; Kostouros E; Karandreas N; Dimopoulos MA
    Clin Colorectal Cancer; 2016 Sep; 15(3):e133-40. PubMed ID: 27038553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system.
    Binder A; Stengel M; Maag R; Wasner G; Schoch R; Moosig F; Schommer B; Baron R
    Eur J Cancer; 2007 Dec; 43(18):2658-63. PubMed ID: 17855072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ibudilast for prevention of oxaliplatin-induced acute neurotoxicity: a pilot study assessing preliminary efficacy, tolerability and pharmacokinetic interactions in patients with metastatic gastrointestinal cancer.
    Teng C; Reuter SE; Blinman PL; Dhillon HM; Galettis P; Proschogo N; McLachlan AJ; Vardy JL
    Cancer Chemother Pharmacol; 2020 Oct; 86(4):547-558. PubMed ID: 32949265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive Acupuncture Point Treatment with Diluted Bee Venom Relieves Mechanical Allodynia and Restores Intraepidermal Nerve Fiber Loss in Oxaliplatin-Induced Neuropathic Mice.
    Yeo JH; Yoon SY; Kwon SK; Kim SJ; Lee JH; Beitz AJ; Roh DH
    J Pain; 2016 Mar; 17(3):298-309. PubMed ID: 26604098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of duloxetine response in patients with oxaliplatin-induced painful chemotherapy-induced peripheral neuropathy (CIPN): a secondary analysis of randomised controlled trial - CALGB/alliance 170601.
    Smith EM; Pang H; Ye C; Cirrincione C; Fleishman S; Paskett ED; Ahles T; Bressler LR; Le-Lindqwister N; Fadul CE; Loprinzi C; Shapiro CL;
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26603828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxaliplatin-associated neuropathy: a review.
    Cersosimo RJ
    Ann Pharmacother; 2005 Jan; 39(1):128-35. PubMed ID: 15590869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.